Tag: embargo policy

Digital Channels, Tools and Platforms to Scale Press Releases, Media Briefings & Embargoes Effective communication is essential in clinical research, particularly when disseminating important findings and updates such as the Natalee clinical trial results. This guide provides a step-by-step approach to utilizing digital channels, tools, and platforms for scaling press releases, media briefings, and embargoes…

Read More “Digital Channels, Tools and Platforms to Scale Press Releases, Media Briefings & Embargoes” »

KPIs, Dashboards and Analytics to Measure Press Releases, Media Briefings & Embargoes Success In today’s competitive landscape of clinical research and pharmaceutical development, effective communication can significantly influence public perception and stakeholder engagement. The utilization of key performance indicators (KPIs), dashboards, and analytics is essential for measuring the success of press releases, media briefings, and…

Read More “KPIs, Dashboards and Analytics to Measure Press Releases, Media Briefings & Embargoes Success” »

Managing Risks, Misinformation and Backlash in Press Releases, Media Briefings & Embargoes In the context of clinical trials, particularly the veeva clinical trials, effective communication is crucial for ensuring clarity, fostering trust, and mitigating potential backlash from stakeholders. This comprehensive guide outlines the steps required to manage risks associated with media releases, briefings, and embargoes…

Read More “Managing Risks, Misinformation and Backlash in Press Releases, Media Briefings & Embargoes” »

Case Studies: Press Releases, Media Briefings & Embargoes That Strengthened Reputation and Engagement In an era where clinical research is increasingly scrutinized by the public and regulatory bodies, effective communication strategies have become vital for pharmaceutical and clinical organizations. This comprehensive guide provides a step-by-step exploration of how press releases, media briefings, and embargoes can…

Read More “Case Studies: Press Releases, Media Briefings & Embargoes That Strengthened Reputation and Engagement” »

Global Considerations for Press Releases, Media Briefings & Embargoes in the US, UK and EU Effective communication is essential during clinical trials, especially when it comes to disseminating results to the public and stakeholders. With the increasing complexity of regulations in the US, UK, and EU, understanding the intricacies involved in drafting press releases, conducting…

Read More “Global Considerations for Press Releases, Media Briefings & Embargoes in the US, UK and EU” »

Press Releases, Media Briefings & Embargoes: Best Practices for Biopharma and Clinical Research In the evolving landscape of biopharmaceutical development and clinical research, effective communication plays a critical role. The public’s understanding and perception of new clinical findings significantly depend on how information is disseminated. This article provides a comprehensive guide on best practices for…

Read More “Press Releases, Media Briefings & Embargoes: Best Practices for Biopharma and Clinical Research” »

How to Plan and Execute Press Releases, Media Briefings & Embargoes for High-Impact Programs How to Plan and Execute Press Releases, Media Briefings & Embargoes for High-Impact Programs In the realm of clinical trials, effective communication can significantly impact public perception and stakeholder engagement. This article outlines a step-by-step tutorial on planning and executing press…

Read More “How to Plan and Execute Press Releases, Media Briefings & Embargoes for High-Impact Programs” »

Press Releases, Media Briefings & Embargoes in Practice: Playbooks, Examples and Checklists Effective communication in clinical trials is paramount, especially when disseminating results that can influence public health and regulatory decision-making. Mastery of press releases, media briefings, and embargoes is crucial for professionals in clinical operations, regulatory affairs, medical affairs, and communications sectors. This article…

Read More “Press Releases, Media Briefings & Embargoes in Practice: Playbooks, Examples and Checklists” »

High-ROI Press Releases, Media Briefings & Embargoes Strategies That Build Trust and Visibility In today’s clinical research landscape, effective communication is paramount to the success of clinical trials, such as crm clinical trial initiatives. Press releases, media briefings, and embargoes play a crucial role in disseminating trial results and building trust with stakeholders, including patients,…

Read More “High-ROI Press Releases, Media Briefings & Embargoes Strategies That Build Trust and Visibility” »

Aligning Press Releases, Media Briefings & Embargoes With Regulatory, Legal and Compliance Requirements Aligning Press Releases, Media Briefings & Embargoes With Regulatory, Legal and Compliance Requirements Effective communication during clinical trials, particularly in the context of psoriatic arthritis clinical trials, is paramount for maintaining the integrity of the study, the protection of participants, and the…

Read More “Aligning Press Releases, Media Briefings & Embargoes With Regulatory, Legal and Compliance Requirements” »